(Q40293590)

19 September 2017

title

Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil (English)

1 reference

Alexander Roberto Precioso

19 September 2017

0 references

1 reference

1 reference

4

1 reference

19 September 2017

R T Mahoney

1

1 reference

19 September 2017

D P Francis

2

1 reference

19 September 2017

N M Frazatti-Gallina

3

1 reference

19 September 2017

I Raw

5

1 reference

19 September 2017

P Watler

6

1 reference

19 September 2017

P Whitehead

7

1 reference

19 September 2017

S S Whitehead

8

1 reference

19 September 2017

language of work or name

English

0 references

publication date

8 March 2012

1 reference

19 September 2017

1 reference

19 September 2017

volume

30

1 reference

19 September 2017

issue

32

1 reference

19 September 2017

page(s)

4892-4896

1 reference

Experiments in social responsibility

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

Dengue and dengue hemorrhagic fever epidemics in Brazil: what research is needed based on trends, surveillance, and control experiences?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

A prospective study of dengue infections in Bangkok

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

Immune response to dengue virus and prospects for a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

Estimating potential demand and supply of dengue vaccine in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

Forecasting dengue vaccine demand in disease endemic and non-endemic countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

Cost of plasma-derived hepatitis B vaccine production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.064

10.1016/J.VACCINE.2012.02.064

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference